Atochina Elena N, Beers Michael F, Tomer Yaniv, Scanlon Seth T, Russo Scott J, Panettieri Reynold A, Haczku Angela
Pulmonary, Allergy & Critical Care Division, Department of Medicine, University of Pennsylvania, School of Medicine, Philadelphia, PA, USA.
Respir Res. 2003 Dec 8;4(1):15. doi: 10.1186/1465-9921-4-15. Print 2003.
C57BL/6 mice have attenuated allergic airway hyperresponsiveness (AHR) when compared with Balb/c mice but the underlying mechanisms remain unclear. SP-D, an innate immune molecule with potent immunosuppressive activities may have an important modulatory role in the allergic airway response and the consequent physiological changes. We hypothesized that an elevated SP-D production is associated with the impaired ability of C57BL/6 mice to develop allergic AHR.
SP-D mRNA and protein expression was investigated during development of allergic airway changes in a model of Aspergillus fumigatus (Af)-induced allergic inflammation. To study whether strain dependency of allergic AHR is associated with different levels of SP-D in the lung, Balb/c and C57BL/6 mice were compared.
Sensitization and exposure to Af induced significant airway inflammation in both mouse strains in comparison with naïve controls. AHR to acetylcholine however was significantly attenuated in C57BL/6 mice in spite of increased eosinophilia and serum IgE when compared with Balb/c mice (p < 0.05). Af challenge of sensitized C57BL/6 mice induced a markedly increased SP-D protein expression in the SA surfactant fraction (1,894 +/- 170% of naïve controls) that was 1.5 fold greater than the increase in Balb/c mice (1,234 +/- 121% p < 0.01). These changes were selective since levels of the hydrophobic SP-B and SP-C and the hydrophilic SP-A were significantly decreased following sensitization and challenge with Af in both strains. Further, sensitized and exposed C57BL/6 mice had significantly lower IL-4 and IL-5 in the BAL fluid than that of Balb/c mice (p < 0.05).
These results suggest that enhanced SP-D production in the lung of C57BL/6 mice may contribute to an attenuated AHR in response to allergic airway sensitization. SP-D may act by inhibiting synthesis of Th2 cytokines.
与Balb/c小鼠相比,C57BL/6小鼠的过敏性气道高反应性(AHR)有所减弱,但其潜在机制尚不清楚。SP-D是一种具有强大免疫抑制活性的天然免疫分子,可能在过敏性气道反应及随之而来的生理变化中发挥重要的调节作用。我们推测,SP-D产生增加与C57BL/6小鼠发生过敏性AHR的能力受损有关。
在烟曲霉(Af)诱导的过敏性炎症模型中,研究过敏性气道变化发展过程中SP-D mRNA和蛋白的表达。为研究过敏性AHR的品系依赖性是否与肺中不同水平的SP-D有关,对Balb/c和C57BL/6小鼠进行了比较。
与未致敏对照相比,致敏并暴露于Af可在两种小鼠品系中诱导显著气道炎症。然而,与Balb/c小鼠相比,尽管嗜酸性粒细胞增多和血清IgE增加,C57BL/6小鼠对乙酰胆碱的AHR仍显著减弱(p<0.05)。致敏的C57BL/6小鼠经Af攻击后,表面活性物质相关(SA)表面活性剂组分中的SP-D蛋白表达显著增加(为未致敏对照的1,894±170%),比Balb/c小鼠的增加幅度高1.5倍(1,234±121%,p<0.01)。这些变化具有选择性,因为在两个品系中,致敏并经Af攻击后,疏水性的SP-B和SP-C以及亲水性的SP-A水平均显著降低。此外,致敏并暴露的C57BL/6小鼠支气管肺泡灌洗液中的IL-4和IL-5显著低于Balb/c小鼠(p<0.05)。
这些结果表明,C57BL/6小鼠肺中SP-D产生增加可能有助于减弱对过敏性气道致敏的AHR。SP-D可能通过抑制Th2细胞因子的合成发挥作用。